Hansa Biopharma AB, a pioneer in enzyme technology for rare immunological conditions, announces that the Company has entered into an agreement with U.S.-based NovaQuest...
RegeneRx Biopharmaceuticals, Inc., a clinical-stage drug development company focused on tissue protection, repair, and regeneration, is reporting today that its U.S. joint venture (JV)...
Natera, Inc., a global leader in cell-free DNA testing, announced that it has received written confirmation from the CMS Molecular Diagnostics Services Program (MolDX)...
Retia Medical, an innovator in advanced hemodynamic monitoring, announced that it has secured $15 million in Series B funding. The financing round was led...
DuraStat LLC, a medical device company innovating in the area of surgical tissue closure, announced it has received an Innovative Technology contract from Vizient,...
